Learning Objectives:

  • Learning Objective 1: Understand the typical steps and regulatory oversight of vaccine clinical development
  • Learning Objective 2: Understand the differences between FDA approval and emergency use authorization
  • Learning Objective 3: Appreciate the unusual considerations for rapid vaccine development and deployment in the setting of an ongoing pandemic
Session date: 
06/20/2024 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Doran Fink, MD, PhD